CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-11 | DUGGAN ROBERT W Director | Purchase | +6,054 | $16.74 | $101K | 42,178,057 |
| 2024-12-11 | DUGGAN ROBERT W Director | Purchase | +50,000 | $17.42 | $871K | 42,228,057 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise | +3,000 | $11.00 | $33K | 93,880 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise | +1,240 | $11.00 | $14K | 21,240 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise | +322 | $11.00 | $4K | 8,321 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise | +322 | $11.00 | $4K | 8,421 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise | +322 | $11.00 | $4K | 8,521 |
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −1,500 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −1,500 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −620 | 1 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −620 | 1 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-24 | Levinson Mitchell E. Chief Strategy Officer | Option exercise · Warrant (right to buy) | −161 | 0 | ||
| 2024-09-12 | DUGGAN ROBERT W Director | Purchase | +145,140 | $14.41 | $2.1M | 47,709,140 |
| 2024-09-11 | DUGGAN ROBERT W Director | Purchase | +12,800 | $14.77 | $189K | 47,564,000 |
| 2024-08-09 | LAVIOLETTE PAUL A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 6 of 15 · 292 trades